Cargando…
CB(1) receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
We have shown previously that the cannabinoid receptor agonist CP55940 microinjected into the paraventricular nucleus of the hypothalamus (PVN) of urethane-anaesthetized rats induces depressor and pressor cardiovascular effects in the absence and presence of the CB(1) antagonist AM251, respectively....
Autores principales: | Grzęda, Emilia, Schlicker, Eberhard, Toczek, Marek, Zalewska, Iwona, Baranowska-Kuczko, Marta, Malinowska, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203819/ https://www.ncbi.nlm.nih.gov/pubmed/27659492 http://dx.doi.org/10.1007/s00210-016-1302-y |
Ejemplares similares
-
Involvement of GABAergic and Adrenergic Neurotransmissions on Paraventricular Nucleus of Hypothalamus in the Control of Cardiac Function
por: Mendonça, Michelle M., et al.
Publicado: (2018) -
Cross-Talk between CB(1), AT(1), AT(2) and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive Controls
por: Mińczuk, Krzysztof, et al.
Publicado: (2022) -
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2014) -
Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea
por: Kaczmarski, Piotr, et al.
Publicado: (2023) -
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)